The SPÖ will stick to their current favorite topic in the final plenary week of the 2021/2022 session in the National Council, which starts Wednesday, and will table an “urgent motion” to Chancellor Karl Nehammer (ÖVP) on the topic of inflation. Deputy club boss Jörg Leichtfried, among others, called on the government on Tuesday to intervene in the market and regulate electricity prices.
In addition, the chancellor is being asked to skim off the billions in profits of the energy companies. Rent increases should be withdrawn and VAT should be suspended for a limited time. He is afraid that the high prices will eventually no longer be affordable for the population, says Leichtfried.
“The so-called price inflation package has not lowered any price”
He accused Nehammer of going into hiding. This is due to the fact that he “unleashed on the population a so-called inflation package that did not lower any price”. In contrast, while many are now overdrawn on their accounts or falling back on savings, companies no longer know “how to keep their vaults closed”.
Wöginger/Maurer: “Very intensive half year”
ÖVP club president August Wöginger and Greens club president Sigrid Maurer were pleased with their work before the parliamentary final started on Wednesday. All in all, according to Wöginger, it has been a “very intensive” six months. But there are also three intensive plenary days with about 40 decisions in total about 40 hours. In the current hour, the three anti-inflation packages will be highlighted again.
The next three days should show that people’s problems can be solved, Maurer added. The rise in prices moves people and therefore measures were quickly taken to ease the burden. But they also want to combat the causes of evil, Maurer referred, among other things, to the Renewable Heat Act (EWG), which was sent for testing.
Source: Krone
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.
